alexa
Reach Us +44-1647-403003
Reviewer - Eswar Shankar | Case Western Reserve University | 171
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Share This Page

Eswar Shankar

Eswar Shankar
Case Western Reserve University
USA

Biography

Cancer biologist with 10 years’ experience in academic research. Extensive experience working in small molecules, ligands, and natural compounds as chemotherapeutic agents in prostate, kidney, bladder, breast and ovarian cancers. Strong background in signal transduction, chemoprevention, chemo-resistance and inflammation. Significant contributions include identifying the role of: Protein Kinase C epsilon as a pivotal inhibitor of TRAIL induced cell death in breast cancer, NSC109268 as an agent inducing Cisplatin sensitivity in ovarian cancer, High Fat Diet induced inflammation as a cause for prostate cancer, Survivin/TGF-β/mTORC1 Axis in prostate epithelial cell growth. Key findings demonstrated through 15 peer reviewed publications. Serving as a reviewer for PLOSE ONE, Journal of Cancer Therapy (JCT) and Journal of Cancer Science and Therapy. Previous work experience is in quality assurance in medical device/bulk drug industries from India.

Research Interest

Small molecules, ligands, and natural compounds as chemotherapeutic agents in prostate, kidney, bladder, breast and ovarian cancers. Strong background in signal transduction, chemoprevention, chemo-resistance and inflammation. Significant contributions include identifying the role of: Protein Kinase C epsilon as a pivotal inhibitor of TRAIL induced cell death in breast cancer

Global Speakers in the subject

Global Experts in the subject

Relevant Topics
Top